AI Diagnostic Platform Company Noul Enters Cancer Diagnostic Business with the Launch of Cervical Cell Analysis Product
YONGIN, South Korea, Oct. 9, 2023 /PRNewswire/ -- Noul Co., Ltd., (376930.KR), an Artificial Intelligence (AI) based blood and cancer diagnostic platform company, has newly introduced 'miLab™ Cartridge CER', a cervical cell analysis product at the International Federation of Gynecology and Obstetrics 2023.